Protagenic Therapeutics, Inc. (PTIX) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -410.42K | -1.49M | -1.17M | -1.07M | -819.79K | -185.66K | -1.55M | -1.66M | -1.14M | -655.77K | -1.53M | -371.83K |
| Operating CF Margin % | - | - | - | - | 3260.51% | - | - | - | - | - | - | - |
| Operating CF Growth % | 49.94% | -705.04% | 24.78% | 35.63% | 28.37% | 71.69% | -1.31% | -346.22% | -532.51% | -22.52% | -80.83% | 13.64% |
| Net Income | 5.83M | -4.49M | -5.06M | -1.44M | -1.55M | -640.78K | -1.61M | -1.72M | -1.68M | -1.4M | -1.21M | -718.1K |
| Depreciation & Amortization | 0 | 230.78K | 12.57K | 12.57K | 12.57K | 12.57K | 12.57K | 12.57K | 26.62K | 1.42K | 91 | 90 |
| Stock-Based Compensation | 206.83K | -5.02K | 125.13K | 236.01K | 245.44K | 250.4K | 265.44K | 161.86K | 166.71K | 166.71K | 166.71K | 166.71K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -219.94K | 23.18K | 118.95K | 0 |
| Other Non-Cash Items | -6.73M | 3.21M | 3.3M | 0 | -80.41K | 0 | -51.53K | -198 | 734.94K | 4.45K | 25.18K | 29.33K |
| Working Capital Changes | 283.09K | -441K | 448.33K | 123.4K | 556.35K | 192.15K | -171.83K | -109.13K | -176.57K | 545.11K | -633.07K | 150.13K |
| Change in Receivables | 2.52K | 0 | -25.11K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 20 | -57 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 388.75K | -442.19K | 265.01K | 0 | 0 | 0 | 0 | 0 | -134.54K | 0 | 0 | 0 |
| Cash from Investing | -943.18K | 943.18K | 943.18K | 0 | 0 | 0 | 1.6M | 1.2M | 2.28M | 590.72K | 1.61M | 294.67K |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -93.97K | -55.81K | 0 | 0 |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | -943.18K | 0 | 943.18K | 0 | 0 | 0 | 0 | 0 | -2.37K | 68.78K | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 943.18K | 0 | 0 | 0 | 51.73K | 0 | 0 | 2.37K | -68.78K | 1.61K | 0 |
| Cash from Financing | 0 | -15.41K | 4.42M | 102.52K | 1.6M | 316.96K | 44.53K | 0 | 0 | 0 | 0 | 0 |
| Debt Issued (Net) | 0 | -15.41K | 77.76K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 0 | 0 | 395.47K | 102.52K | 1.6M | 316.96K | 44.53K | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 3.95M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | -509.81K | 1.85M | 4.08M | -965.51K | 782.66K | 131.21K | 92.82K | -456.12K | 1.13M | -66.11K | 80.94K | -76.7K |
| Free Cash Flow | -410.43K | -1.49M | -1.17M | -1.07M | -819.79K | -185.66K | -1.55M | -1.66M | -1.24M | -711.57K | -1.53M | -371.83K |
| FCF Margin % | - | - | - | - | 3260.51% | - | - | - | - | - | - | - |
| FCF Growth % | 49.94% | -705.04% | 24.78% | 35.63% | 33.8% | 73.91% | -1.31% | -346.22% | -577.68% | -32.95% | -80.83% | 13.64% |
| FCF per Share | -0.21 | -0.81 | -0.32 | -2.04 | -0.13 | -0.04 | -0.35 | -0.37 | -0.28 | -0.16 | -0.35 | -0.09 |
| FCF Conversion (FCF/Net Income) | -0.19x | 1.72x | 0.23x | 0.74x | 0.53x | 0.29x | 0.97x | 0.96x | 0.68x | 0.47x | 1.27x | 0.52x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |